Erythromycin ethylsuccinate is an ester prodrug of erythromycin, designed to improve oral bioavailability and palatability. It is used to treat a variety of bacterial infections by inhibiting protein synthesis. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as acne agents and anti-infectives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include anamycin and Erythromycin. Its PubChem CID is 443953.
Erythromycin ethylsuccinate
| CAS No | 1264-62-6 |
|---|---|
| Molecular Formula | C43H75NO16 |
| Molecular Weight | 862.1 g/mol |
| Synonyms | 4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin ethylsuccinate is an ester prodrug of erythromycin, designed to improve oral bioavailability and palatability. It is used to treat a variety of bacterial infections by inhibiting protein synthesis.
The listed CAS number is 1264-62-6.
The listed molecular formula is C43H75NO16.
The listed molecular weight is 862.1 g/mol.
4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate.
The source lists anamycin and Erythromycin.